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1. Introduction 
Glucocorticoids are well known to play an important role in the regulation of most essential 
physiological processes (Atanasov & Odermatt,2007). Patients with Cushing`s syndrome show 
central obesity with insulin resistance, caused by hypersecretion of cortisol (F) (Arnaldi et 
al.,2004). Obese patients with type 2 diabetes often have symptoms usually observed in 
patients with Cushing`s syndrome, and F levels might reflect the severity of complications and 
metabolic abnormalities in diabetes (Chiodini et al.,2007). High levels of F are associated with 
activation or dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis and increased 
volume of the adrenal glands (Pasquali et al.,2006, Godoy-Matos et al.,2006). 
Moreover, various metabolic abnormalities induced by enhanced glucocorticoid activity were 
found to be not only due to accelerated function of the HPA axis, but also by an impairment in 
11β-hydroxysteroid dehydrogenase (11β-HSD) enzymes within the target cells (Godoy-Matos 
et at.,2006). 11β-HSD has two isoforms: 11β-HSD type 1 (11β-HSD1) mainly works as a 
reductase which converts inactive cortisone (E) to active cortisol (F) in F target tissues (Walker 
& Andrew,2006). 11β-HSD type 2 (11β-HSD2) is expressed in mineralocorticoid target tissues 
such as the distal nephron, colon, and salivary glands (Tannin et al.,1991, Draper & Stewart, 
2005, Edwards et al., 1988), converting F to E to protect mineralocorticoid receptors from 
activation by F. 
Animal models demonstrated that activation of 11β-HSD1 exhibited features of metabolic 
syndrome (Masuzaki et al.,2004, Morton et al.,2004). It was also reported that 11β-HSD1 is 
increased in subcutaneous adipose tissue in obese patients (Rask et al.,2002, Paulmyer-
Lacroi et al.,2002), and higher 11β-HSD1 activity in adipose tissue is associated with features 
of metabolic syndrome in Caucasians and Pima Indians (Lindsay et al.,2003). Thus, it is 
suggested that F may play a crucial role in the regulation of adiposity in type 2 diabetes 
with obesity. On the other hand, the exact role of abnormal glucocorticoid metabolism in the 
pathogenesis of obesity has not fully been clarified yet. Salivary cortisol has been reported to 
be in closer agreement with the real adrenocortical function than serum cortisol 
concentration (Bolufer et al.,1989). Measurement of salivary cortisol was also reported to 
have several advantages, such as directly reflecting free cortisol level (Vining et al.,1983), 
and non-invasiveness for sampling (Chen et al.,1985). We, therefore, analyzed samples from 
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serum, saliva, and 24h-collected urine from obese type 2 diabetic patients as well as healthy 
subjects in order to evaluate clinical usefulness of salivary cortisol accurately measured by 
liquid mass spectroscopy in obese patients with type 2 diabetes. 
2. Subjects and methods 
2.1 Subjects 
Eighteen Japanese men without underlying diseases cooperated as the healthy subject group. 
As the patient group, 23 Japanese male patients with type 2 diabetes, admitted to the Department 
of Endocrinology and Metabolism in Yokohama Rosai Hospital between March 2006 and 
March 2007, who met the following conditions were selected:1) waist circumference of 85 cm or 
greater, 2) stage 1 or 2 diabetic nephropathy, 3) not treated with oral biguanide or thiazolidine 
derivatives, and 4)understanding the objective of this study and giving written consent. This 
study was approved by the research ethics committee of Yokohama Rosai Hospital. 
2.2 Measurement of serum and salivary steroids  
Five ml of blood and 1 ml of saliva were collected before breakfast and supper on the same 
day under regular conditions of daily life from the controls and patients. Furthermore, 5ml 
of blood and 1ml of saliva 2 hours after breakfast, lunch and supper, and 20 ml of 24-h 
accumulated urine were collected on the same day during hospitalization on 7 days after 
admission from the patient group. The diet consisted of 25kcal/kg for ideal body weight 
distributed in three meals. 
Blood samples were immediately centrifuged, and the sera were stored at -30C until 
measurement. Saliva and accumulated urine samples were stored with no processing at -30C.  
Cortisol and cortisone in the samples were measured by liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) (Teikoku Hormone Mfg.-Asuka Pharmaceutical Co., Tokyo, Japan).  
2.3 Glucose clamp 
Euglycemic-hyperinsulinemic glucose clamping was performed in 14 of the patient group 
using an artificial pancreas (STG-22, Nikkiso, Tokyo, Japan), following the method 
described previously (Bergman et al.,1985, Nishikawa et al.,1996). Average age, HbA1c and 
BMI of these patients were not significantly different from those of the whole cases in  
 
 
(data expressed as mean ±SD) 
Table 1. Anthropometric measures and background of the subjects 
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patient group. In patients under drug treatment for diabetes, administration of sulfonylurea  
and a long-acting insulin preparation was suspended from the previous evening to avoid 
their influence on the test.  
2.4 Statistical analysis  
The subjects’ backgrounds are presented as the means  standard deviation, and the t-test 
was used to compare healthy subjects with patients. To analyze the correlation between 2 
variables, Spearman’s correlation coefficient was used, and a level of less than 5% was 
regarded as significant. 
3. Results 
3.1 Subject characteristics  
The characteristics of the healthy and patient group, including age and BMI, are described in 
Table 1. The mean duration of illness was 7.0  4.7 years in the patient group, and 14 (60.9%) 
and 8 (34.8%) patients were under treatment with insulin and oral drugs, respectively at the 
time of sample collection.  
 
 
Serum levels of F and E were not different between healthy subjects and diabetic patients (A), and the 
ratio of F to E was significantly higher in the patient group (B). A similar result was observed for saliva 
(C, D). Data are expressed as the means±S.D. Statistical significance between healthy and diabetic 
subjects is described inside the figure. 
Fig. 1. Comparison of F, E, and F/E ratios between healthy subjects and diabetic patients in 
the fasting phase in the morning. 
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3.2 Relationship between F/E ratio and body weight 
As shown in Fig. 1, no significant difference was noted in the blood cortisol (F) level before 
breakfast between the healthy and patient group, but the cortisone (E) level was lower in the 
patient group. Accordingly, the ratio of F to E (F/E) in blood was significantly higher in the 
patient group (3.6 vs. 4.8, respectively, p<0.01). 
There was no significant difference in F or E level in saliva before breakfast between the 
healthy and patient group. Unlike the blood levels, E level was higher than F level in saliva. 
This is considered to be the influence of 11β-HSD2 expressed in the salivary gland (Tannin 
et al.,1991). However, the F/E ratio in saliva was significantly higher in the patient group, as 
in blood (0.13 vs. 0.19, respectively, p<0.01).  
There was no correlation between the blood F/E ratio before breakfast and body mass index 
(BMI) in healthy subjects (Fig.2A), while there was a strong positive correlation between the 
blood F/E ratio and BMI in the patient group (Fig.2B). This correlation also remained 
significant after correction with age, HbA1c and blood glucose level before breakfast. 
Furthermore, a similar result was observed in salivary samples.  The salivary F/E ratio 
tended to show a positive correlation with BMI in diabetic patients, but not in healthy 
subjects (Fig.2C, D).   
 
 
F/E ratio in blood was positively correlated with BMI only in diabetic patients (A, B). F/E ratio from 
salivary samples also showed a similar tendency, although the correlation was not statistically 
significant in diabetic patients (C, D). 
Fig. 2. Correlation between fasting F/E ratio and BMI. 
Fig. 3 shows the relationship between the fasting blood F/E ratio and fat volume assessed 
by abdominal CT in the patient group. The F/E ratio was positively correlated with the 
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subcutaneous fat area, but was not correlated with the area of visceral fat. Furthermore, the 
fasting blood and salivary F/E ratio was strongly correlated with serum leptin level 
(r=0.652, p<.0.01 for blood, r=0.469, p<.0.05 for saliva), but was not correlated with the 
plasma concentration of high molecular weight adiponectin or the severity of insulin 
resistance measured by glucose clamping (data not shown). 
 
 
Fasting blood F/E ratio positively correlated with subcutaneous fat area (A), but no correlation was 
found between F/E ratio and visceral fat area (B). 
Fig. 3. Relationship between fasting blood F/E ratio and body fat area assessed by CT scan. 
3.3 Relationship between salivary cortisol and insulin sensitivity  
Blood and saliva were collected at 4-time points: before breakfast and 2 hours after each 
meal in the patient group. Fig. 4 shows the diurnal variation of F after assessing the level 
before breakfast as 1.0. The F level significantly decreased with time and the variation was 
larger in saliva than in blood. The within-day variation of the F/E ratio was smaller than 
that of the F level. 
 
 
Solid line represents blood samples, and dotted line represents salivary samples. Both blood and saliva 
had a circadian rhythm in the patients, but salivary F fluctuated more dynamically than blood cortisol 
within a day.  
Fig. 4. Circadian rhythm of F (A) and F/E ratio (B) in diabetic patients. 
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The salivary F level after breakfast was strongly correlated with the severity of insulin 
resistance measured by the glucose clamp (Fig. 5). This relationship with insulin resistance 
was not significantly noted in blood F.  
 
 
Salivary F after breakfast showed the strongest negative correlation with GIR/IRI (A, B), while serum 
F(C, D) does not show significant correlation with insulin sensitivity. 
Fig. 5. Relationship between insulin sensitivity (GIR/IRI) and F. 
4. Discussion 
The present study clearly demonstrated that obese patients with type 2 diabetes had a 
higher fasting F/E ratio in blood and saliva in the morning, comparing with healthy control 
subjects. Consistent with our results, an elevated blood F/E ratio in patients with type 2 
diabetes has been reported (Valsamakis et al.,2004, Homma et al.,2001, Sinha & Caro 1998). 
Moreover, this is the first report demonstrating a significant increase in the F/E ratio in 
obese diabetic patients in saliva as well as in blood. Thus, it is suggested that overweight 
seems to induce much more F formation rather than E production via some mechanism(s) of 
changing steroidogenic enzymes, including 11β-HSD1 and 2.  
Our data also showed a positive relationship between the fasting F/E ratio and BMI, 
between the fasting F/E ratio and total fat volume, and between the fasting F/E ratio and 
leptin, in diabetic obese patients. It is, therefore, suggested that the fasting F/E ratio may 
reflect the severity of adiposity accumulated to both of subcutaneous and visceral areas in 
obese diabetics, since circulating leptin levels are reported to be the best predictor of total 
body fat mass (Sinha & Caro,1998). Thus it can be postulated that increased fat mass may 
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lead to increased F production, at least partly mediated by 11β-HSD1 in adipose tissue, 
resulting in an elevated F/E ratio after overnight fasting. It was also reported that the 
expression of 11β-HSD1 is increased in adipose tissue in simple obesity (Rask et al.,2002, 
Paulmyer-Lacroi et al.,2002, Lindsay et al.,2003), suggesting that the ratio of F to E is a 
biomarker for assessing the adiposity in obese patients. 
Oltmanns et al. (Oltmanns et al.,2006) recently reported that the level of salivary F of which 
sample was taken between breakfast and lunch was significantly related to metabolic 
findings in type 2 diabetes, such as fasting and postprandial blood glucose, urinary glucose, 
and glycosylated hemoglobin, although insulin sensitivity was not directly assessed in their 
study. Our data demonstrated that a circadian rhythm of F was apparently observed both in 
blood and saliva, and salivary F 2 hours after breakfast was shown to significantly correlate 
with insulin sensitivity assessed by euglycemic glucose clamping in obese patients with type 
2 diabetes. Salivary F has been reported to have a circadian rhythm, highest in the morning, 
with lunch followed by a peak (Rosmond et al.,1998), suggesting that the salivary level of F 
usually decreases before lunch under normal conditions. Thus, it is suggested from our data 
that the level of salivary F before lunch, reflecting insulin sensitivity, may be up-regulated 
by food intake after breakfast despite of decreasing ACTH level by diurnal rhythm, since 
eating was reported to stimulate F secretion and women with abdominal obesity have also 
been reported to have a greater rise of F in response to food than those with peripheral 
obesity in simple obesity (Pasquali et al.,1998, Duclos et al.,2005, Korbonits et al.,1996). It 
had been recently reported that U-shaped associations were apparent between diurnal slope 
in salivary F and both BMI and waist circumference (Kumari et al.,2010), and also that 6 wk 
of supplementation with fish oil significantly increased lean mass and decreased fat mass, 
which were significantly correlated with a reduction in salivary F following fish oil 
treatment (Noreen et al.,2010). 
Moreover, we should consider why salivary F could reflect insulin resistance in diabetic 
patients, while blood F could not. First, F measured in blood was the total of the free form 
and protein-bound form, while F in saliva reflected the biologically active blood unbound F 
level (Vining et al.,1983). The level of blood F can be altered by the concentration of blood F 
binding globulin (CBG), and CBG levels are shown to correlate negatively with BMI, waist-
to-hip ratio, and HOMA (Fernandez-Real et al.,2002). Hence, salivary F is supposed to 
indicate the level of ‘real’ F activity in vivo, and thus correlates strongly with insulin 
resistance. Second, as shown in Fig. 4, salivary F fluctuates more dynamically than blood F 
within a day. None of our patients were diagnosed as overt or subclinical Cushing 
syndrome, and their levels of F were within the normal range. However, even a small 
increase in blood F within the normal range may contribute to abnormal glucose metabolism 
in metabolic syndrome and type 2 diabetes (Khani & Tayek,2001), and salivary F seems to be 
more sensitive than blood F to detect subtle changes in the metabolic state. 
On the other hand, our results demonstrated that there is not significantly positive 
correlation between salivary F after breakfast and visceral fat mass. Visceral fat volume is 
known to be one of the most important factors to determine insulin resistance (Bergman et 
al.,2007), but our data suggest that F has a significant influence on insulin resistance, and 
intimately related to total fat volume. Furthermore, many factors including levels of glucose 
and insulin are supposed to modulate F metabolism after meals. Therefore, measuring 
salivary F after breakfast in obese diabetic patients may be a useful and noninvasive simple 
method to predict overall insulin sensitivity and severity of adiposity in such patients. 
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In conclusion, we tried to investigate the role of blood and salivary F and E in the regulatory 
mechanisms of obesity in obese men with type 2 diabetes. They had a higher fasting F/E 
ratio in both blood and saliva than that in healthy controls. Moreover, the fasting F/E ratio 
showed a significant correlation with total fat volume, suggesting that the fasting ratio of F 
to E in saliva and blood seems to directly reflect the adiposity in type 2 diabetic patients 
with obesity. Our data also demonstrated that salivary F after breakfast is suggested to be 
one of the most useful markers of insulin sensitivity in these patients. On the other hand, 
our study was conducted with a cross-sectional design, which does not allow us to assume 
any direct causality of F to insulin resistance. The role of F metabolism in adipogenesis and 
insulin resistance in type 2 diabetes will require further investigation with a prospective 
design.  
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